MedTrace Logo

Airflow Limitation in Cardiac Diseases in Europe

NCT01485159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2014-02-24

No results posted yet for this study

Summary

This is a cross-sectional, observational study, investigating the point prevalence of Airflow Limitation in current or former smokers with established ischemic heart disease. The study will recruit up to 3000 patients from cardiology clinics at hospitals across Europe.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

PROCEDURE

Spirometry

assessment of lung function by spirometry

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Belgium
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Netherlands
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01485159 on ClinicalTrials.gov